An update on the efficacy and safety of aclidinium bromide in patients with COPD
Aclidinium is a potent and selective muscarinic antagonist, which interacts rapidly with muscarinic receptors and shows subnanomolar affinity for the five human muscarinic receptors (M 1 –M 5 ); its association rate for the M 3 receptor is similar to that of ipratropium and 2.6 times faster than tha...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2011-02-01
|
| Edice: | Therapeutic Advances in Respiratory Disease |
| On-line přístup: | https://doi.org/10.1177/1753465810381546 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|